Hot Flasher

Hot Flasher. Daily menopause podcast. Because we all had the same question and nobody had a good answer.

Hot Flasher is a health podcast hosted by Unknown Host, with 103 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Unknown Host hosts Hot Flasher, a health show with 103 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #107

  When Menopause Gets Dark: Suicidality, Bone Clues & a Big New Study

  Aug 21, 202610 minS1

  This episode covers a qualitative study on how fragmented care systems fail women experiencing suicidality during menopause, a promising new blood marker for detecting bone thinning early, and the launch of one of the most detailed long-term menopause studies ever designed. Friday format — research grounded, lighter in places, and worth your weekend thinking. Key Takeaways: • A 2026 qualitative study found that clinicians and caregivers consistently identified fragmented, siloed care as a key failure point when menopausal women reached a mental health crisis — menopause and mental health services often don't talk to each other. • Suicidality during perimenopause and menopause is real and documented, but it remains dramatically undertreated and under-recognized in primary care. • Xylosyltransferase-I (XT-I) is a blood enzyme that may signal bone thinning earlier than current standard tests — still early-stage research, but worth watching. • The KiSO-DP cohort study will track women through the full menopausal transition using biological, psychological, and lifestyle data collected from the same participants over time — the kind of within-person design that produces much more reliable answers than snapshot studies. • Research on menopause is getting more ambitious and more rigorous — and the questions being asked are finally catching up to what women have been reporting for decades. Sources & References: • Menopausal suicidality and fragmented care: carer and clinician perspectives (https://pubmed.ncbi.nlm.nih.gov/42625547/) - PubMed • Xylosyltransferase-I as a biomarker for postmenopausal osteoporosis (https://pubmed.ncbi.nlm.nih.gov/42624941/) - PubMed • KiSO-DP: Women in healthy transition deep phenotyping cohort study protocol (https://pubmed.ncbi.nlm.nih.gov/42624590/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-08-21-listener-story Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  ListenShow Notes
• 

  Episode #106

  35 Lost Workdays, Stolen Sleep, and the Story Nobody's Telling

  Aug 20, 20269 minS1

  This episode covers three things getting attention right now: new data showing menopause symptoms cost workers nearly 35 workdays a year, a 2026 study linking menopausal insomnia directly to dementia risk, and a NAMS journal paper raising the intersection of intimate partner violence and menopause care — a conversation that's been missing from the field for too long. Key Takeaways: • New research estimates that perimenopause and menopause symptoms cost employees nearly 35 workdays per year in lost productivity — not just absences, but impaired performance while present. • A 2026 PubMed study frames menopausal insomnia as a point in the chain leading to dementia risk — and, critically, as something that can be addressed, which means sleep isn't just about feeling rested. • Poor sleep during menopause disrupts the brain's overnight cleanup process, which is directly tied to the kind of protein buildup associated with Alzheimer's disease. • A paper in the NAMS journal identifies intimate partner violence as an underexplored factor in menopause care — abuse affects stress hormones, sleep, and access to healthcare in ways that can make symptoms significantly worse. • Women in abusive situations may have their menopause symptoms dismissed, undertreated, or go entirely unaddressed — and clinicians currently have almost no training to recognize the overlap. Sources & References: • Perimenopause and menopause symptoms may cost employees nearly 35 workdays a year (https://news.google.com/rss/articles/CBMitAFBVV95cUxNY0RIMzI2ZmlSdXhsV2k4LW5oeFoxTmhOaFEyeU1TdDR5NXVXUU5zQWNWOEJaMC1abVFGQkM4U1hXb0tuNUwxbFFXM2V3MndIMW5GRTBreC05ck5RUENLa2g0SmpsSjNlZFVCQ3g0RU5RZzhZRUs5QmRIRDdVLWgxUzdoamRFZ1FTWkJYMG5aSU12OTJwNUpBNlJVeV9iQkZGN2NtMlhUc0NnbEo2aEUzSWJWMzQ?oc=5) - Fast Company • Menopausal insomnia as a modifiable node of dementia risk: Mechanistic insights and intervention strategies (https://pubmed.ncbi.nlm.nih.gov/42619312/) - PubMed • The overlooked intersection of intimate partner violence and menopause care (https://pubmed.ncbi.nlm.nih.gov/42610458/) - Menopause (NAMS Journal) Listen with full show notes: https://hotflasher.com/episodes/2026-08-20-influencer-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  ListenShow Notes
• 

  Episode #105

  The Menopause Market Is Booming. Here's What's Actually Worth Your Money.

  Aug 19, 20269 minS1

  JAMA takes a hard look at the exploding menopause care market and asks which treatments actually have evidence behind them. A new NAMS study finds that type 2 diabetes significantly worsens menopause symptoms — more than most people realize. And a peer-reviewed paper asks why clinicians almost never screen for intimate partner violence during menopause care visits. Key Takeaways: • The menopause care market is growing fast, but JAMA's review finds the evidence for many emerging treatments hasn't kept pace with the marketing. • Hormone therapy and a small number of non-hormonal options have the strongest research backing; most supplements and "menopause kits" do not. • A Korean study of midlife women found that those with type 2 diabetes reported significantly more menopause symptoms — and more severe ones — than women without diabetes. • Postmenopausal women with type 2 diabetes had a higher overall symptom burden, suggesting blood sugar management may directly affect quality of life during menopause. • Research published in the NAMS journal finds that clinicians rarely screen for intimate partner violence during menopause care visits, despite evidence that IPV affects both access to care and symptom severity. Sources & References: • The overlooked intersection of intimate partner violence and menopause care (https://pubmed.ncbi.nlm.nih.gov/42610458/) - Menopause (NAMS Journal) • Association between type 2 diabetes and menopausal symptoms in Korean midlife women (https://pubmed.ncbi.nlm.nih.gov/42549660/) - Menopause (NAMS Journal) Listen with full show notes: https://hotflasher.com/episodes/2026-08-19-myth-busting Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  ListenShow Notes
• 

  Episode #104

  Why Your Symptoms Hit Harder (And What Your Brain Has to Do With It)

  Aug 18, 202610 minS1

  This episode digs into why some women have significantly worse menopause symptoms than others, looks at the surprisingly plausible case for antihistamines as a symptom tool, and breaks down what a new SWAN study says about midlife inflammation and your future memory. Key Takeaways: • A newly identified biological difference — in how certain women's nervous systems respond to dropping estrogen — may explain why symptom severity varies so much from person to person. • Antihistamines target histamine, a chemical that interacts with the same brain pathways involved in hot flashes and mood swings; the evidence is early but the mechanism is real. • A study from the long-running SWAN research project found that women with higher levels of a specific inflammation marker (GlycA) in midlife had lower working memory scores years later. • Not all inflammation signals worked the same way — two immune proteins (complement C3 and C4) were actually associated with better cognitive outcomes when they increased, which complicates the "all inflammation is bad" narrative. • The SWAN finding points to midlife — not just post-menopause — as a window that may matter for long-term brain health. Sources & References: • Scientists discovered one reason menopause symptoms might be worse for certain women (https://news.google.com/rss/articles/CBMiiAFBVV95cUxNRXJld3p2V09adzdLdk83cUNMMlFnbnlodngxeERaZUJrVFdMV1BFa191TEN4WVZnMjcxc1VYYkJ0YlFhNXVocmFtUDJDby13Sl9Pa0tCQkxJUnoyek03Tlk5RDRSWG50Qks1Y0N2NmlDeHJkeGdrV1ViM2pDcFFZdHhKWXVVTE9q?oc=5) - Women's Health • Can antihistamines really help with PMDD and menopausal symptoms? (https://news.google.com/rss/articles/CBMihAFBVV95cUxNa0Y1bzRYMlZDUlJlamVjZTJjWEZSd1QzMTFVbDBwR1ZPcDcxRGF4ODNxd0lSNUtiQ0dGZXRsNTAzOGFqWVJ6VTVfOGVOU2VZZzRwY2NwVkFZRnRwU1p6Y2RXWUtnTlVRLTZ6eWFwOVV6RzJxUERpSFhzQUZ1cTVXdXEtQlQ?oc=5) - The Guardian • Inflammatory and immune biomarkers over midlife and future cognition in women: the SWAN HDL Ancillary Study (https://pubmed.ncbi.nlm.nih.gov/42549661/) - NAMS Journal / PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-08-18-symptom-spotlight Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  ListenShow Notes
• 

  Episode #103

  Your Brain, Your Bones, and Your Period Tracker Just Sold Your Data

  Aug 17, 202610 minS1

  This episode covers three research and news stories: a new study suggesting hormone therapy may reduce Alzheimer's risk by around 35%, a major meta-analysis confirming that strength training does protect bone density after menopause (with some important caveats on how big that effect actually is), and a data privacy investigation finding that menopause apps have been selling users' intimate health information — and in many cases, still are. Key Takeaways: • A new study found that women who used hormone therapy had roughly 35% lower Alzheimer's risk — but this is observational research, not a clinical trial, and the result does not mean HRT prevents Alzheimer's. • A systematic review of multiple studies found that high-intensity and strength training does increase bone density in postmenopausal women, though the effect sizes were described as small — real, but not dramatic. • The type of exercise matters: impact training (like jumping) and strength training both showed benefits for bone density, and the research supports combining them rather than choosing one. • Multiple menopause apps have sold users' intimate health data — including symptom logs, cycle history, and other private details — often without clear disclosure, and the practice is reportedly ongoing. • If you use a menopause or period tracking app, it is worth checking its privacy policy specifically for language about data sharing with third parties or "partners." Sources & References: • Alzheimer's risk may be 35% lower with common menopause treatment, study finds (https://news.google.com/rss/articles/CBMipAFBVV95cUxPR2M3NVFTQktWaW5Pc3dMcWNwZnNfUnhtaGRnZlpwSHIzUjNUU1JmaTZ5aFdsWnl1WXRaQ2R1YlYyMm5wWmVkdGc3bHkxSjI5ekpHdVUzMExoX1hDRllScHcwX3ZBSnJUVVItNFZzeFZRcUZTUGtjbElZc0dpTkU1ekdzLXhXcHNBcUd5VExRUEVWSzZ6ZUM3dWFPYVNYVlpNUmY4RdIBqgFBVV95cUxQQm5Gd3F0S01iejNscTdTcDNEZEhQeGNadGJNV1VMRnVwMG1peUVOakkzeDRZZDFrNVdXaXF5YkUwb1R1elUyanVkNHMtRVFjdDVtRlNtMDJsdU5iWVBNM3QzWHdfYl9SaHBCLWxnZWM4cHBmNzk2b09jSzBBZnNDMldjQ3hBVUl2bENHOUd6RjdpWFpkLXFnLUpWd3Z0M1NFUXNRN0Y0Tk5oZw) - Fox News • Systematic review and meta-analysis: high-intensity, impact, and strength training effects on bone density in pre- and postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42578477/) - Menopause (NAMS Journal) via PubMed • Millions of women's intimate health data has been sold by menopause apps — and it's still happening (https://news.google.com/rss/articles/CBMilAFBVV95cUxNTWlUVjlzbkdfVVQ2MTUxa29PWXo4WVk1RG9TRjk3UFpYbkVhb1JXbEpGeFA3bkdPWGpGeWRqaF9lTVFRdG9sbUtXUERKamdHdWZLUTNZRFRGZFJDOG1sY1VYTjRTRTBDNTVXaGRiU3FXQUlHS0tuQldYdDJtV2xHSEZxODdwUjRoa1lFRnVuektnZ1Q2) - The Independent Listen with full show notes: https://hotflasher.com/episodes/2026-08-17-research-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  ListenShow Notes

Recent guests on Hot Flasher. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.